Drugs & TargetsFree Lenvima gets European approval for advanced, unresectable hepatocellular carcinoma August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves pembrolizumab + chemo for first-line metastatic non-squamous NSCLC August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA updates prescribing information for Keytruda, Tecentriq August 31, 2018Vol.44 No.32
Drugs & TargetsFree Nivolumab gets accelerated approval for third-line metastatic small cell lung cancer August 31, 2018Vol.44 No.32
Drugs & TargetsFree FDA approves Kyowa Kirin’s Poteligeo for mycosis fungoides and Sézary Syndrome August 31, 2018Vol.44 No.32
Drugs & Targets TheraBionic P1 device receives European regulatory approval August 03, 2018Vol.44 No.31
Drugs & Targets Keytruda + pemetrexed and platinum gets EMA’s positive opinion for first-line NSCLC August 03, 2018Vol.44 No.31
Drugs & Targets Tafinlar + Mekinist gets positive CHMP opinion for adjuvant BRAF V600 mutation-positive melanoma August 03, 2018Vol.44 No.31
Drugs & Targets Lenvima + Keytruda get Breakthrough designation for endometrial carcinoma August 03, 2018Vol.44 No.31
